A Memorandum of Understanding (MoU) signed between the Ministry of Health and Child Care (MoHCC) and the China National Institute of Parasitic Diseases (NIPD), will see Zimbabwe becoming a manufacturing powerhouse for Praziquantel, a drug used to treat Schistosomiasis, also known as snail fever or bilharzia. By Michael Gwarisa This comes after Zimbabwe was selected to become the first country to benefit under the Africa-China Cooperation for the Elimination of Schistosomiasis program, which targets to capacitate African countries to manage and control the spread and infection of Bilharzia in communities.…
Read MoreTag: MoU
Zimbabwe Signs MoU With Swiss Pharmaceutical Giant
ZIMBABWE signed a memorandum of understanding with a Swiss headquartered pharmaceutical company Novartis for patients to access medicines for non-communicable diseases at nominal prices. By Kudakwashe Pembere The signing ceremony done last week will see Zimbabwe each person get medicines for NCDs such as hypertension, diabetes and breast cancer for a dollar a month from Novartis’s unit, Sandoz DD. Speaking after the announcement of the MoU, Dr Moyo expressed confidence that the collaboration would help provide improved health care and reduce preventable deaths. “The issue of access to medicines is…
Read More